A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2011
11/30/2011	CN102258467A 静脉注射用缓释青蒿素及其衍生物脂肪乳的配方及制备 Intravenous fat emulsion sustained-release formulations of artemisinin and its derivatives and preparation
11/30/2011	CN102258464A 高浓度抗体和蛋白制剂 High concentrations of antibody and protein formulations
11/30/2011	CN102258463A 一种稳定的亚叶酸钠注射液 Asia leaves a stable sodium injection
11/30/2011	CN102258462A 一种提高盐酸氨溴索稳定性的方法 Method for improving the stability of ambroxol hydrochloride method
11/30/2011	CN102258459A 一种瑞舒伐他汀钙口服固体制剂及其应用 One kind of rosuvastatin calcium oral solid dosage forms and applications
11/30/2011	CN102258458A 一种用于退热的直肠用原位凝胶剂及其制备方法 Rectal gel in situ method for its preparation antipyretic
11/30/2011	CN102258457A Non-aqueous composition
11/30/2011	CN102258455A 一种甾体激素类涂膜剂及其制备方法 A body balm and a preparation method of hormonal steroids
11/30/2011	CN102258454A 一种包衣的冻干赋形制剂 One coating forming lyophilized preparations
11/30/2011	CN102028663B 一种稳定的奥美沙坦酯固体制剂 A stable solid preparation olmesartan medoxomil
11/30/2011	CN101982190B 采用透皮吸收技术治疗外感风寒型感冒的外用霜剂 Using transdermal treatment of exogenous cold type cold topical cream
11/30/2011	CN101919813B Method for preparing chitosan nanoparticles with recombinant human endostar for injection
11/30/2011	CN101889983B PEG-PLGA nanoparticle carrying recombinant human vascular endothelial inhibitor and preparation method thereof
11/30/2011	CN101843588B 联苯双酯纳米脂质载体及其制备方法 DDB nanostructured lipid carrier and its preparation method
11/30/2011	CN101829175B 一种快速崩解的珍菊降压片剂及其制备方法 Zhenjujiangya tablets and preparation method of rapidly disintegrating
11/30/2011	CN101829119B 头孢地秦钠组合物及其粉针 Cefodizime sodium composition and powder for injection
11/30/2011	CN101816636B 一种单硝酸异山梨酯的冻干粉针剂及其制备方法 A freeze-dried powder mononitrate isosorbide dinitrate and its preparation method
11/30/2011	CN101808619B 制备含有至少一种抗原和至少一种辅助剂的疫苗组合物的方法 The method of preparing a vaccine composition comprising at least one antigen and at least one adjuvant of the
11/30/2011	CN101768276B 聚乙二醇单甲醚-聚己内酯-聚乙烯亚胺三嵌段共聚物及其应用 Polyethylene glycol monomethyl ether - polycaprolactone - polyethylene imine triblock copolymer and its Applications
11/30/2011	CN101757169B 一种提高公猪精子活力的天然植物制剂及其制备方法 An increase natural plant preparations boar sperm motility and its preparation method
11/30/2011	CN101756939B 一种右旋酮洛芬包衣缓释微粒胶囊 One kind of right-handed particles coated slow-release capsules Ketoprofen
11/30/2011	CN101744824B 头孢硫脒化合物的组合物制剂及其制备方法 The composition and its preparation method cefathiamidine compounds
11/30/2011	CN101735418B 生物可降解阳离子聚合物及其应用 Biodegradable cationic polymer and its application
11/30/2011	CN101732285B 一种阿昔莫司的胶囊剂 One kind Acipimox capsules
11/30/2011	CN101732270B 一种缬沙坦的分散片及其制备方法 Tablet and preparation method valsartan
11/30/2011	CN101716161B 一种胸腺肽壳聚糖微球口服药物制剂及其制备方法 Chitosan microspheres oral pharmaceutical formulation and preparation of thymosin
11/30/2011	CN101716141B 一种氟罗沙星注射液及其制备方法 An injection Fleroxacin fluoride and its preparation method
11/30/2011	CN101712798B 金属纳米粒子与细胞膜仿生修饰树枝状聚酰胺-胺复合物及制备方法 Metal nanoparticles modified dendritic cell Bionic polyamide - amine compound and preparation method
11/30/2011	CN101626755B 包含酸不稳定药物的双单元片剂 Dual unit tablet comprising an acid labile drug
11/30/2011	CN101618023B 一种制备微粉化蛋白的方法 A method for preparing a protein powder
11/30/2011	CN101574411B 一种双丹口腔崩解片 A dual Dan orally disintegrating tablet
11/30/2011	CN101554376B 一种高生物利用度的雷帕霉素组合物及制备方法 A highly bioavailability rapamycin compositions and methods for preparing
11/30/2011	CN101524333B 阿莫西林分散片及其生产方法 Amoxicillin tablet and its production method
11/30/2011	CN101502649B 一种脂质体流感疫苗 Liposome influenza vaccine
11/30/2011	CN101474256B 一种苍耳子鼻炎软胶囊制剂及其制备方法 One kind of Xanthium rhinitis soft capsule and its preparation method
11/30/2011	CN101444476B 新微球和其生产方法 The new microspheres and its production method
11/30/2011	CN101439187B 胆汁酸-抗肝炎病毒药物偶合物及其制药用途 Bile acid - anti-hepatitis C virus drug conjugate and pharmaceutical use
11/30/2011	CN101417008B 作为中兽药复方制剂的注射用双黄连及其制备工艺与应用 SHL injection technology and application in veterinary medicine and its preparation as a compound preparation
11/30/2011	CN101376022B 含聚乙二醇降纤酶的药物组合物 Containing polyethylene glycol defibrase pharmaceutical compositions
11/30/2011	CN101199631B 一种含有微粉硅胶的软胶囊及其制备方法 Micronized silica-containing soft capsule and its preparation method
11/30/2011	CN101194906B 一种用于治疗过敏性疾病的滴丸及其制备方法 Dropping Pills and its preparation method for the treatment of allergic diseases
11/30/2011	CN101182379B 用于膜和胶囊的高抑制性淀粉填料 High inhibit starch fillers for films and capsules
11/30/2011	CN101163486B 阿奇霉素在生产用于治疗眼部感染的药物中的用途 Azithromycin use in the manufacture of a medicament for the treatment of eye infections in
11/30/2011	CN101085226B 一种脉络宁注射用粉针剂及其制备方法 One kind Mailuoning powder for injection and its preparation method
11/30/2011	CN101085191B 一种生脉有效部位提取物及其制剂 One kind shengmai effective part extract and its preparations
11/30/2011	CN101085058B 一种含有赤芍和麝香的药物组合物、制备方法和制剂 A pharmaceutical composition containing a red peony and musk, preparation methods and formulations
11/30/2011	CN101085026B 一种含有丹参和麝香的药物组合物、制备方法和制剂 The pharmaceutical compositions containing salvia and musk, preparation methods and formulations
11/29/2011	US8067575 RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)
11/29/2011	US8067553 PEG-urate oxidase conjugates and use thereof
11/29/2011	US8067472 Methods of treating Hodgkin's and non-Hodgkin's lymphoma
11/29/2011	US8067431 Chemically modified small molecules
11/29/2011	US8067427 Pharmaceutical compositions comprising ZD6474
11/29/2011	US8067388 Decoy-containing pharmaceutical compositions and method of using the same
11/29/2011	US8067043 Herbal composition for treatment of hyperlipidemia and the inhibition of myocardial infarction
11/29/2011	US8067031 Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
11/29/2011	US8067030 Controlled release composition and method of producing the same
11/29/2011	US8067022 Therapeutic inhibitor of vascular smooth muscle cells
11/29/2011	US8067020 Sustained release formulation
11/29/2011	US8067017 Preservation of bioactive materials by freeze dried foam
11/29/2011	US8067007 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
11/29/2011	US8067005 Divalent antibody fragments
11/29/2011	CA2641581C Stabilization of solid thyroid drug formulations
11/29/2011	CA2626531C Sodium chloride solution for drug reconstitution or dilution
11/29/2011	CA2613417C Pharmaceutical preparation containing an angiotensin ii receptor antagonist and a calcium channel blocker
11/29/2011	CA2535364C Hyaluronic acid nanoparticles
11/29/2011	CA2486910C Ophthalmological use of roflumilast for the treatment of diseases of the eye
11/29/2011	CA2479711C Formulation
11/29/2011	CA2462580C Utilization of phosphatidylserine in the treatment of attention deficit syndrome (adhs)
11/29/2011	CA2461349C Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
11/29/2011	CA2456327C Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/29/2011	CA2448208C Influenza vaccine composition
11/29/2011	CA2440461C Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
11/29/2011	CA2423227C Reduced-viscosity concentrated protein formulations
11/28/2011	CA2738045A1 Conjugate compounds, methods of making same, and uses thereof
11/27/2011	CA2741179A1 Hydrogel implants with varying degrees of crosslinking
11/27/2011	CA2741142A1 Hydrogel implants with varying degrees of crosslinking
11/27/2011	CA2737706A1 Biodegradable polymer encapsulated microsphere particulate film and method of making thereof
11/24/2011	WO2011146852A2 Foam or particles for applications such as drug delivery
11/24/2011	WO2011146808A2 Topical formulation for a jak inhibitor
11/24/2011	WO2011146801A1 Formulation and dosing of hsp90 inhibitory compounds
11/24/2011	WO2011146689A1 Compositions, systems, and/or methods involving chlorine dioxide ("cio2")
11/24/2011	WO2011146638A1 Compositions and methods for treatment of autoimmune and other diseases
11/24/2011	WO2011146483A1 Drug delivery devices for delivery of ocular therapeutic agents
11/24/2011	WO2011146408A1 Hpma polymer platinum chelates
11/24/2011	WO2011145963A1 Non-leaching nanoparticle formulation for the intracellular delivery of hydrophobic drugs and its use to modulate cell activity and differentiation
11/24/2011	WO2011145745A1 Vesicles with encapsulated substance and production method therefor
11/24/2011	WO2011145660A1 Propofol-containing oil-in-water emulsion composition
11/24/2011	WO2011145659A1 Carotenoid-containing composition and production method therefor
11/24/2011	WO2011145642A1 Pharmaceutical composition containing solifenacin
11/24/2011	WO2011145077A2 Branched polypeptides and their use in promoting adhesion of cells to solid surfaces
11/24/2011	WO2011145068A1 Novel self-reactive arms and prodrugs comprising same
11/24/2011	WO2011144892A1 Cationic lipids
11/24/2011	WO2011144790A1 Composition for the detection of postprandial hypertriglyceridemia
11/24/2011	WO2011144766A1 Pharmaceutical composition of ibuprofen for injection
11/24/2011	WO2011144751A1 Improved anti-serum albumin binding variants
11/24/2011	WO2011144727A1 Preparations of biologically active substances with enlarged surface area based on amphiphilic copolymers
11/24/2011	WO2011144677A1 Pharmaceutical composition of ibuprofen for injection
11/24/2011	WO2011144674A2 PHARMACEUTICAL FORMULATION COMPRISING INSULIN GLARGINE AND SBE4-ß-CYD
11/24/2011	WO2011144650A1 Pharmaceutical aqueous compositions comprising lipoic acid as an antioxidant
11/24/2011	WO2011144358A1 Histidine-containing solution for transfection and/or injection of nucleic acids and uses thereof

1 ... 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 ... 1712